Federal Telehealth Policy Updates for MAT in 2026

Telehealth policy for medication-assisted treatment (MAT) involves several overlapping systems: federal controlled-substance rules, state professional licensing, insurer coverage, privacy requirements, and each provider's clinical policies. A change in one system does not automatically change the others.

Rules and temporary extensions can change quickly. This article provides a verification framework rather than a definitive legal conclusion for every appointment. Patients and clinicians should confirm current requirements through official federal and state sources.

Federal Controlled-Substance Rules

Buprenorphine is a controlled medication. Federal rules determine when a DEA-registered clinician may prescribe controlled substances through telemedicine and what documentation or in-person evaluation may be required.

The policy environment has evolved since the COVID-19 public-health emergency. Temporary flexibilities, proposed rules, and final rules have had different effective dates. Do not assume that a headline about an extension or proposal describes the rule in force today.

For current information, check DEA and U.S. Department of Health and Human Services announcements, the Federal Register, and guidance from the prescribing clinician. A provider may apply a more cautious clinical policy than the federal minimum.

The X-Waiver Is Separate

The federal X-waiver requirement for prescribing buprenorphine for opioid use disorder ended in 2023. That change expanded which appropriately registered practitioners may prescribe, but it did not erase every rule governing controlled substances, telemedicine, state licensing, or standard clinical practice.

Learn more in what the X-waiver elimination means.

State Licensing Still Matters

Telehealth care generally occurs where the patient is physically located during the appointment. A clinician typically needs authority to practice in that state, subject to applicable exceptions and compacts.

Tell the provider where you will be during each visit, especially when traveling or moving. A prescription previously issued in one state does not guarantee that the same clinician can continue telehealth visits while you are in another.

See the overview of state telehealth laws in Virginia, Ohio, and Pennsylvania, then verify the current licensing-board rules.

Medicare, Medicaid, and Commercial Coverage

Legal permission to deliver a service through telehealth does not guarantee insurance coverage. Medicare rules, state Medicaid programs, and commercial plans can use different definitions, eligible providers, billing codes, cost sharing, and audio-only requirements.

Before an appointment, ask:

• Is this provider in network?
• Is this exact telehealth service covered?
• Does the plan require video rather than audio-only care?
• Is an originating site or in-person visit required?
• What deductible, copay, or coinsurance applies?
• Are medication, counseling, and laboratory services billed separately?

Record the representative's name and reference number. Benefit information is not a guarantee of payment, but documentation can help resolve discrepancies.

Audio-Only and Video Visits

Whether audio-only care is permitted or covered depends on the clinical service, payer, state, and current federal rules. Even when legally allowed, a clinician may decide that video or an in-person assessment is needed for safe care.

Patients who lack reliable broadband or a private video-capable device should tell the provider. The care team may be able to explain available formats or identify an appropriate local alternative, but no particular format is guaranteed.

Privacy and Security

Healthcare providers and plans may be subject to HIPAA and, for certain substance-use-disorder records, 42 CFR Part 2. These rules have detailed scopes and exceptions; they should not be reduced to a promise of absolute confidentiality.

Patients can improve practical privacy by using a private space, securing devices and portals, reviewing notification previews, and asking how bills and messages are labeled. Providers should use approved systems, verify identity, document consent when required, and explain emergency procedures.

Read more about telehealth privacy.

What Patients Should Confirm

Before beginning telehealth MAT, ask the provider:

1. In which states can you treat a patient who is physically present there?
2. Is an in-person examination required now or later?
3. Which visit formats are available?
4. How are prescriptions sent and pharmacy problems handled?
5. What happens if technology fails during an appointment?
6. How should urgent symptoms or an overdose emergency be handled?
7. Which insurance plans currently participate?

Clinical induction, dosing, and tapering decisions must be individualized by the prescriber. A policy article is not a medication-starting guide.

What Clinicians Should Verify

Clinicians should use current primary sources and organizational counsel to verify DEA registration, state authority, prescribing requirements, documentation, informed consent, privacy, payer rules, and emergency planning. Proposed legislation and agency announcements should not be treated as effective law until their status and date are confirmed.

Accessing Care

Grata Health offers telehealth OUD treatment in Virginia, Ohio, and Pennsylvania. Clinical eligibility, appointment availability, visit format, insurance participation, and any in-person requirements should be confirmed for each patient.

Contact Grata Health to ask what options are currently available. If someone may be experiencing an overdose, severe breathing problems, or another emergency, call 911 instead of waiting for a telehealth response.